Canada’s research and development landscape is entering a new phase of adjustment. As federal plans shift toward a business‑led R&D model, the anticipated arrival of the Canada Innovation Corporation in 2026–27 signals a structural change in how early‑stage science connects with market application. This delay has left research teams and founders re‑examining their roadmaps, seeking clarity on which public programs or private pathways best fit their work while the policy frame
